Proteins pair to help alpha-synuclein spread in brain: Study
Two proteins, Aplp1 and Lag3, pair to allow toxic aggregates of alpha-synuclein — a hallmark of Parkinson’s disease —…
Articles by Margarida Maia, PhD
Poor adherence to Nourianz linked to anxiety, mood changes
People with Parkinson’s disease who don’t always take Nourianz (istradefylline) as prescribed are more likely to have fewer…
ioAstrocytes join Bit.bio’s portfolio of cells to model Parkinson’s
Synthetic biology company Bit.bio introduced ioAstrocytes, a stem cell-derived version of astrocytes, cells that are known to play a…
Phase 2 AB-1005 gene therapy trial for Parkinson’s starts recruiting
A Phase 2 clinical study of AB-1005 (AAV2-GDNF), an experimental gene therapy AskBio is developing for Parkinson’s disease,…
Coya extends research collaboration into exosomes from T-cells
Coya Therapeutics is building upon its collaboration with the Houston Methodist Research Institute, in Texas, to advance research into…
Blood test may predict Parkinson’s disease years before symptoms
Researchers at University College London (UCL) have developed a test that accurately identified Parkinson’s disease up to seven years…
Brain rewiring eases Parkinson’s symptoms before DBS is turned on
Changes in how regions of the brain interact with each other, which occur during the surgical procedure for deep…
Levodopa boosts brain connections to ease Parkinson’s resting tremor
Taking levodopa, the mainstay of treatment for Parkinson’s disease, results in two key brain regions for movement strongly…
Contaminants pose risk as use of cannabis for Parkinson’s rises: Study
The use of medical cannabis in the U.S. has grown as more states legalize it, and programs listing Parkinson’s…
Lactulose may ease constipation due to Parkinson’s, study finds
Lactulose — a synthetic (lab-made) sugar used to soften stools — may ease symptoms of constipation in people with…